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Abstract 
Mitochondrial DNA (mtDNA) that codes protein subunits essential for the maintenace of mitochondrial ATP synthesis ystem 
acquires mutations ata much igher ate than that in nuclear DNA. Recent study has revealed that somatically acquired mutations such as 
deletions in mtDNA are caused mainly by oxygen free-radical damage. Cumulative accumulation f these somatic mutations during the 
life of an individual causes bioenergetic deficit leading to cell death and normal ageing. The base-sequencing of the entire mtDNA from 
48 individuals revealed that germ-line point mutations accelerate extensively the somatic oxygen free-radical damage and the deletions 
leading to generation of more than a hundred kinds of mtDNA minicircle. These accelerated somatic mutations are expressed as 
premature ageing of the patients with degenerative diseases. Comprehensive analyses of the entire mtDNA, including the total 
base-sequencing and the total deletion correlating with oxygen free-radical damage, has revealed a clear relationship between the 
genotype and its phenotype, such as the severity of clinical symptoms and the survival time of the patients. Extensive generation of 
mtDNA minicircles caused by the oxygen free radical implies a close relation between the redox mechanism of ageing and the 
programmed cell-death machinery. 
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1. Introduction 
The free-radical theory of ageing, proposed by Harman 
in 1956 [1], that free radicals cause non-specific damage to 
macromolecules, such as DNA, lipids, and proteins, has 
attracted much attention in recent years due to develop- 
ments in free-radical biology. There is enough supporting 
evidence, such as the reciprocal relation between the maxi- 
mum life span and the specific metabolic rate among 
animals. However, this theory has not been totally persua- 
sive because biologically active oxygen-damaged macro- 
molecules, such as lipid peroxides or oxidized proteins, 
usually do not accumulate, but turn over at a certain 
metabolic rate, with the exception of merely biologically 
inactive degenerative products uch as lipofuscin or amy- 
loid. In fact, no adequate bio-marker to support he theory 
has been established. 
In 1959, the first clinical syndrome related to mitochon- 
drial dysfunction was reported by Ernster, Ikkos and Luft 
[2] and later referred to as Luft's disease, the etiological 
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background of which remains unknown. In the early 
1960's, some people still believed in de novo synthesis of 
mitochondria from cytoplasmic membrane. However, in 
1964, the presence of mitochondrial DNA (mtDNA) in 
yeast was reported [3], and the existence of mtDNA, a 
closed circular duplex DNA, among several biological 
species was confirmed by extensive studies during 1970's. 
In 1981, the entire nucleotide-sequence of human mtDNA 
of 16569 basepairs (bp) was reported [4] and later com- 
monly referred to as the Cambridge Sequence (Camb. 
Seq.). During the 1980's, reports accumulated on the 
abnormality of mitochondrial gene products [5,6] as well 
as mtDNA itself associated with the degenerative diseases 
and even with age [7,8]. In 1989, we proposed [9] that the 
somatic accumulation of mitochondrial genome mutations 
during life is a major cause of human ageing and degenera- 
tive diseases. This mitochondrial theory of ageing is based 
on the following facts: the high frequency of gene muta- 
tion in mtDNA; the small size of the mitochondrial genome 
and its known information content; the lack of a repair 
mechanism for mtDNA, unlike nuclear DNA; the somatic 
segregation of individual mtDNA during eukaryotic ell 
division. Since 1989, the newly invented polymerase chain 
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reaction (PCR) has been put to practical use. With the aid 
of PCR, many kinds of mtDNA mutations, such as point 
mutation and deletion, have been shown to be associated 
with ageing and degenerative diseases. Thus, the theory of 
mitochondrial geing and diseases caused by mtDNA mu- 
tations has been widely accepted. Yet, the correlation 
between the genotype and the clinical phenotype of an 
individual has remained to be clarified. 
Recent findings that the cumulative increase in oxygen 
free-radical damage in mtDNA correlates closely with that 
in deletion associated with age [ 10,11 ] could coordinate the 
free-radical theory and the mitochondrial theory of ageing. 
Namely, it was found that the human mtDNA is a superb 
bio-marker of cellular oxygen free-radical damage over a 
period of years. We reported the presence of mtDNA with 
a 5 kilobasepair (kbp) deletion, later referred to as the 
common deletion, in the striatum of patients with Parkin- 
son's disease (PD) as well as in that of aged subjects, as 
shown in Fig. 1 [8]. Subsequently, the common deletion 
was found in various human tissues associated with age 
[12,13]. Several other kinds of large deletions were re- 
ported in the patients with premature ageing such as 
Kearns-Sayre syndrome [14], primary cardiomyopathy [15], 
or diabetes with deafness [16]. Underlying mechanism for 
a large deletion is double-strand separation leading to the 
generation of long stretches of single-stranded DNA. Ac- 
cumulation of hydroxyl-radical dducts in mtDNA hydro- 
lysate, such as 8-hydroxydeoxyguanosine (8-OH-dG) in 
place of deoxyguanosine (dG), could satisfy this pre- 
requisite to the deletion [11]. Because of the conforma- 
tional change [17], 8-hydroxyguanine in mtDNA would 
play a key role in yielding double-strand separation and 
deletion. Especially in post-mitotic cells, the mitochondrial 
genome mutations accumulate during life by escaping the 
excision repair and cellular selection by mitosis. Quantita- 
tive analyses of oxygen free-radical damage in mtDNA 
using mass spectrometry (MS) as well as those of deletions 
by PCR revealed a synergistic and exponential increase in 
the somatic oxygen free-radical damage and the deletions 
in normal human subjects as well as in aged experimental 
animals [18]. The total detection system for deletion, using 
180 kinds of primer pairs [19], revealed that the germ-line 
point mutations triggered the extensive increase in the 
amount of deletions, leading to the generation of over a 
hundred kinds of mtDNA minicircle associated with the 
oxygen free-radical damage, as shown in Fig. 2. In our 
laboratory, much effort has been expended in the base-se- 
quencing of the entire mtDNA. Accumulated ata from 48 
individuals revealed istinct clustering of point mutations 
and phylogeny among patients with mitochondrial diseases 
[20,21]. The phylogenic tree of mtDNA mutations among 
patients with mitochondrial cardiomyopathy (mtCM) is 
shown in Fig. 3 [22]. This revealed that the difference in 
even an additional single point-mutation compared with 
the control (MCM, P-1 vs. ID l l9)  resulted in an extensive 
difference in the amount of somatic deletions, as shown in 
Fig. 2. Over a period of years, the difference in the 
severity of germ-line mutation was demonstrated to be 
closely related to the patients' phenotype, e.g., abnormal 
mitochondrial morphology (Fig. 4), and ultimately their 
life span (Fig. 5). Comprehensive analyses of the entire 
mtDNA, the base-sequence and the total deletion with 
oxygen free-radical damage, revealed a clear correlation 
between the genotype and the clinical phenotype. 
This accumulated evidence urges unification of both 
ideas of the free radical and mitochondrial theory of 
ageing to become "the redox mechanism of ageing" : that 
the oxygen free-radical damage of mtDNAs results in a 
cumulative increase in somatic mutations in mtDNA, lead- 
ing to bioenergetic deficit, cell death, and ageing. The 
germ-line mutations in mtDNA specific for patients with 
mitochondrial diseases accelerate these pathological pro- 
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Fig. 1. Presence ofthe deleted mtDNA in the striatum ofpatients with PD. The deleted mtDNA in the striatum of patients with PD was detected by the 
PCR. The mtDNA fragments were amplified using a primer pair [8], separated ona 1% agarose gel, and stained with etbidium bromide. Lanes 1-6, the 
normal controls; and lanes 7-11, the patients with PD. Both the normal controls and the patients with PD are arranged in the order of age. Sizes of 
amplified fragments are indicated inkbp. The band amplified from the normal mtDNA is indicated by an arrow. The abnormal band of 0.77 kbp amplified 
from the deleted mtDNA is indicated by an asterisk. 
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Fig. 2. Extensive deletions leading to generation of mtDNA minicircles. The total detection system for all kinds of deletions in mtDNA was designed with 
180 different primer pairs [19]. In the heart mtDNA of a patient died of heart failure at age 19 (MCM, P-1 in Fig. 3) having a (syn-) mutation in the 
tRNA A~p gene, 235 types of deletion leading to generation of mtDNA minicircles are detected. Deletions could be classified into four groups: A group of 
deleted mtDNA (total 48 types) having the preserved replication origin (Or) for the H-strand (OrH) and for the L-strand (OrL), B group having OrH but no 
OrL(total 59), C group having OrL but no OrH (total 31), and D group having neither OrH nor OrL (total 97). Group B, C, and D, either incomplete or 
complete losses of Or, are regarded as mtDNA minicircle. Numbered mtDNAs with various sizes of deletion are sequenced including crossover region of 
the deletion breakpoints. The deleted mtDNA accounted for 84% of the patient's total mtDNA. In contrast to the patient, 67 types of deletion accounting 
for 23% of the total mtDNA were detected in mtDNA of the ( syn)  negative control, a woman died from an accident at age 28 ( IDl l9 in Fig. 3). Her 
deleted mtDNA also consisted of the four groups. 
cesses, leading to their phenotypic expression as premature 
ageing. Recent reports that the oxygen free radical, gener- 
ated mainly in mitochondria [23], causes the extensive 
deletions leading the generation of mtDNA minicircles 
[19] suggest that there is a close relation between the redox 
mechanism of ageing and the programmed cell death 
machinery regulating oxygen free-radical damage, up-regu- 
lated by a protooncogene product, Bax [24], and down-reg- 
ulated by Bcl-2 [25]. The mutation in mtDNA seems to 
cause imbalance of the inherent mitochondrial ntioxidant 
pathways and of the control of the protooncogenes (Fig. 
2). 
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Fig. 4. Abnormal mitochondria n myocardium of the patient. The patient died of heart failure at age 19 (MCM, P-1 in Fig. 3). His heart was autopsied 1h 
alter death. A myocardium specimen was examined by electron microscopy. Abnormally expanded mitochondria proliferated, and muscle fibers showed 
severe atrophic and regressive changes. 
2. Molecular genetics of mtDNA mutations 
The basic pathological processes in ageing and mito- 
chondrial diseases involve mutations in mitochondrial 
genomes that code essential parts of the energy-transduc- 
ing system. Apart from a minor contribution from anaero- 
bic glycolysis, the ATP is almost exclusively produced by 
mitochondria. This ATP production depends upon the 
proper functioning of the mitochondrial electron-transport 
chain, and of the functionally coupled protonmotive ATP- 
synthase (ATPase) associated with the inner mitochondrial 
membrane. Mitochondria carry out the Krebs cycle and the 
/3-oxidation pathway for fatty acids. These degradative 
sequences essentially remove hydrogen from metabolic 
fuels and transfer it through coenzymic arriers to the 
electron-transport chain. The chain then transfers these 
reducing equivalents eventually to react with molecular 
oxygen, with the production of H20. This latter process is 
achieved in a manner that transduces the redox energy into 
a proton gradient as the driving force for ATP synthesis. 
ATP is the direct driving force for virtually all energy-de- 
manding process of living cells. Accordingly, deterioration 
of the electron-transport chain and ATPase leads to cellu- 
lar dysfunction and cell death. 
Another important feature of the electron-transport chain 
is the generation of reactive oxygen species. A certain 
percentage of electrons from the chain is accepted by 
molecular oxygen, transforming to oxygen free radicals. In 
early studies, this phenomenon was observed as the an- 
timycin-insensitive respiration that was around 5% of the 
total mitochondrial oxygen consumption [26]. Ernster pro- 
posed oxygen as an environmental poison based on the 
estimation that around 1%-2% of the total oxygen con- 
sumption is turned into to oxygen free radicals [27]. Thus, 
during the life of individual, a vast sum of redox energy is 
consumed to activate the molecular oxygen to its reactive 
Fig. 3. Clustering of point mutations in mtDNA among patients with mtCM. From the total base-sequencing of 48 individuals including 14 mtCM patients, 
the base-sequence of mtEve is deduced. Divergence from the mtEve of the Camb. Seq. [4] is also deduced from our data-base. Among the mtCM patients, 
subsequently diverged base-substitutions aredemonstrated together with their nucleotide positions. The base-substitutions including several point mutations 
are illustrated by abbreviations: / ,  transition; - ,  transversion; Ins, insertion of nucleotide; Del, deletion of nucleotide; *, mutation that changes amino acid 
residue; !, mutation that changes evolutionary conserved amino acid residue; #, non-conserved base substitution i tRNA gene; @, mutation in tRNA 
gene. The unique base-substitutions f the patient are enclosed with the identification of the patient (P) with sex, age of death (f) or of genetic examination 
and major arrhythmia. HCM: Hypertrophic ardiomyopathy. DCM: Dilated cardiomyopathy. MCM: Mitochondrial cardiomyopathy. ID: Identification 
number for the legal anatomy. 
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Fig. 5. Cumulative survival rate of the patients with mitochondrial 
diseases. The deceased patients and their (syn-)  mutations were as 
follows: a patient with fatal infantile cardiomyopathy died at age I year, 
having a C-to-T transition at nucleotide position 3254 in the tRNA teu~uuR) 
gene, a 4317A-to-G in the tRNA lie gene and a 5554 C-to-T in the 
tRNA vrp gene [23]; a patient with MELAS died at age 14, havinga 3243 
A-to-G in the tRNA eeu~UuR) gene and a 5601 C-to-T in the tRNA Ala gene 
[20]; a patient with mtCM died at age 19 (MCM, P-1 in Fig. 3), having a 
7579 T-to-C in the tRNA A~p gene [22]; a patient with MELAS died at age 
20, having a 3243 A-to-G in the tRNA t~uOTuR) gene [20]; a patient with 
HCM died at age 21, having a 14678 A-to-G in the tRNA 61u gene and a 
15928 G-to-A in the tRNA TM gene [22]; a patient with MERRF died at 
age 21, having a 8344 A-to-G in the tRNA Ly~ gene [20]; a patient with 
HCM died at age 45, having a 5821 G-to-A in the tRNA cys gene and a 
15951 A-to-G in the tRNA Thr gene [21]; a patient with DCM died at age 
45, having a 4386 T-to-C in the tRNA GIn gene [21]; a patient with HCM 
died at age 53, having a 4386 T-to-C in the tRNA Gl" gene [22]. The 
deceased patients who had only (mit-) mutation were as follows: a patient 
with PD died at age 72 [20]; a patient with DCM died at age 75 [21]; a 
patient with PD died at age 77 [20]. 
species. In addition, cytochrome c, an essential component 
of the chain, is demonstrated to be over 20-times more 
efficient than ferrous ion [28] for catalyzing the Fenton 
reaction, transforming hydrogen peroxide to hydroxyl radi- 
cal, the most reactive oxygen free-radical species. There- 
fore, the electron-transport chain could be regarded as the 
efficient plant of hydroxyl radical production, essential for 
the programmed cell death, apoptosis, that is a fundamen- 
tal process for morphogenesis and development from em- 
bryo to adult, homeostasis, and defense to viral infection 
[29]. Thus, reactive oxygen species could not be regarded 
as mere by-products of the mitochondrial respiration, but 
as energy-dependent ac ive products having an important 
role, presumably, as essential parts of the programmed cell 
death machinery. 
Recent advances in analysis of mtDNA mutations have 
demonstrated not only the germ-line mutations transmitted 
from ancestors, but also the somatic mutations acquired 
during the life of an individual. The analyses of the 
somatic mutations have indicated the underlying mecha- 
nism as the oxygen free-radical damage. 
2.1. Germ-line mutations 
We defined the base substitutions causing amino-acid 
substitutions in the protein-coding enes as (mit-) muta- 
tions, and the substitutions of nucleotides in the tRNA 
gene at the sites conserved among animal species or those 
disrupting the conserved basepairings in the stem struc- 
tures of the tRNA essential for the mitochondrial protein 
synthesis as (syn-) mutations, according to the nomencla- 
ture of yeast mtDNA mutations [30]. The major germ-line 
mutation among patients with mitochondrial diseases is 
(mit-), which often associates with (syn-), converting the 
genotype to (mi t -+ syn-). Thus, the genotypes of the 
patients could be classified into two major groups: (mit-) 
and (mit- + syn- ). 
One complication in the analysis of germ-line point 
mutations has been the lack of a normal standard base-se- 
quence of human mtDNA indispensable to any survey of 
(mit-) and/or (syn-) mutation. Although the major part 
of the Camb. Seq. was derived from a single placenta 
mtDNA, some regions were derived from HeLa cell 
mtDNA [4]. In addition, several ambiguous nucleotides 
were assumed to be the same as in the bovine mtDNA 
sequence. Thus, the Camb. Seq. can not be regarded as the 
normal standard sequence for the studies on mitochondrial 
diseases. Wallace et al. implied some error of the Camb. 
Seq. [31]; however, their argument was also not fully 
documented. On the other hand, basing their theory on the 
restriction mapping, the Wilson group concluded that all 
the modem human mtDNAs stem from one woman or one 
group of women, the mitochondrial Eve (mtEve), who 
is/are postulated to have lived about 200000 years ago 
[32]. However, the information derived from the restriction 
enzyme analyses is restricted to only about 9% of the total 
mtDNA sequence. Thus the total base-sequence of the 
mtEve remains unknown. To overcome the lack of a 
normal standard mtDNA sequence, much effort has been 
expended in sequencing the entire mtDNA of 48 individu- 
als of Japanese, American of Irish descent, and Australians 
of English or Greek origin using the fluorescence-based 
direct sequencing method without using cloning [33]. The 
accumulated database of up to one million basepairs per- 
mits us to deduce the total base-sequence of mtEve within 
limited errors and to elucidate the divergence of the Camb. 
Seq. and of individuals from the mtEve. The database 
identifies the definitive genetic pedigrees of the patients 
with mitochondrial disease [22] without using an interest- 
ing but incomplete statistical method to construct phyloge- 
nies from the limited number of base substitutions ob- 
tained by the restriction enzyme assay and/or the partial 
sequencing of the genome [34]. 
As shown in Fig. 3, a phylogenetic tree was constructed 
according to the base-substitutions among the patients with 
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mtCM whose autopsied or biopsied specimens could be 
obtained clinically [22]. Some of the base-substitutions are 
synonymous; however, some are non-synonymous muta- 
tions, (mit-) and/or (syn-). They could produce signifi- 
cant change in the biochemical properties of the gene 
product and thereby initiate the disease. There are no 
predominant point mutations among the patients with PD, 
in contrast o those with some neuromuscular diseases; 
over 80% of the patients with mitochondrial myopathy, 
encephalopathy with lactic acidosis, and stroke-like 
episodes (MELAS) had an 3243 A-to-G transition in the 
tRNA Leu(UUR) gene [35,36], and about 50% of the patients 
with myoclonic epilepsy with ragged red fibers (MERRF) 
had a 8344 A-to-G transition in the tRNA Ly~ gene [37,38]. 
The sequencing of MELAS or MERRF patients' entire 
mtDNA has revealed that, besides the predominant ( syn) ,  
there are usually several (mit-) in a particular patient [20]. 
These facts suggest that not only a single (mit-) or (syn-) 
detected by the restriction enzyme analyses or the partial 
sequencing within a limited area, but also several other 
serious point mutations, detected by the sequencing of the 
entire mtDNA, play an important role in the manifestation 
of mitochondrial disease. 
Comprehensive analyses of the germ-line mutations 
among patients with neuromuscular and cardiovascular 
diseases have demonstrated that effects of these mutations 
are cumulative. Looking through the whole spectrum of 
the point mutations among the patients, we have noticed 
that patients with (mit-+ syn-) genotype usually mani- 
fested more severe clinical symptoms than patients with 
(mi t )  genotype. In yeast, ( syn)  mutants are similar to 
the strains with large deletion, (p )  mutation, in being 
pleiotropically deficient in the respiratory and ATPase 
complexes [30]. Fig. 4 illustrates the cumulative survival 
rate with the genotype of the patients calculated by the 
method of Kaplan and Meier [39]. The median survival 
time of the patients with (mit-+ syn-) is more than 50 
years shorter than that of the patients with only (mit-). 
The clear correlation between the phenotype and the geno- 
type could be interpreted as that (mit- + syn-) point muta- 
tions, together with provoked somatic mutations, shorten 
the survival time despite some complementation f the 
syn- mutations [40,41]. 
Another complication in the analysis of germ-line 
point-mutations is that each mitochondrion contains multi- 
ple copies of mtDNA. Thus, several thousand copies exist 
in a single cell. A recent study [42] on the mutanogenesis 
of the hydroxyl radical adducts of dG, 8-OH-dG, in mam- 
malian cells clearly demonstrated that a synthetic -Ha-ras 
protooncogene containing 8-hydroxyguanine induces ran- 
dom point-mutations at the modified site and adjacent 
positions. As base-sequencing after cloning of mtDNA 
could pick-up one particular base-substitution ut of thou- 
sands of copies, the direct sequencing without cloning [43] 
could avoid such complication. In the case of the germ-line 
point mutations, the mutated bases exist in homoplasmic 
form among tissues and among patients' maternal lineage, 
except in some cases such as the heteroplasmic 3243 
A-to-G transition in the patients with MELAS and in some 
patients with diabetes and deafness [44]. The differing 
phenotypic expression of the homoplasmic point-mutation 
among the members within one lineage could be due to 
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Fig. 6. Correlative increase in the deletion and oxygen free radical 
damage in mtDNA associated with age and mtCM. (A) The ratio of 
deleted mtDNA to the total mtDNA was plotted against the age of 
subjects. The amounts of the total and deleted mtDNA in autopsied 
myocardium of various ages were determined by the kinetic PCR [45]. 
The ratio increases exponentially with age [r = 0.87, P < 0.01]. (B) The 
8-OH-dG content was plotted against the age of subject. Samples of 
mtDNA in the rest of sample after the deletion analysis were enzymati- 
cally hydrolyzed into nucleosides, ubjected to pre-column concentration, 
and analyzed by the micro HPLC/MS system. Total eluent from the 
micro column (0.3 × 150 ram) was directly injected into an MS spectrom- 
eter. Both selected ion monitoring and ionization MS spectra of 8-OH-dG 
and dG were recorded. The ratio of 8-OH-dG to (dG+8-OH-dG) in- 
creases exponentially with the age of subjects [r = 0.84, P < 0.01]. The 
8-OH-dG contents of mtCM patients who died of heart failure at age 17 
(female) and 19 (male, MCM, P-1 in Fig. 3, indicated by an arrow), 
respectively, are plotted with filled circles. The 8-OH-dG content of the 
(syn ) negative control (female, ID 119 in Fig. 3), indicated by an 
arrow) is plotted by open squares. Arrows with dashed line indicated that 
the 8-OH-dG content of MCM, P-1 is equivalent to that of the normal 
subjects of age 78. 
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additional factors such as the type and the amount of 
somatically acquired deletions and/or to imbalance in the 
expression of apoptosis regulating protooncogenes, such 
as bcl-2 and bax gene [24,25]. 
2.2. Somatic mutations 
In yeast, the petite mutations, a characteristic type of 
yeast mtDNA mutation, occurs spontaneously in growing 
cultures at a rate of 10 -1 to 10 -3 of total cell population, 
in contrast to nuclear mutation rate 10 -7 to 10 -8 in 
haploid and 10 -14 to 10 16 in diploid. Similarly, the 
somatic mutation rate of human mtDNA is considered to 
be many times higher than that of nuclear DNA. Reasons 
for the high mutation rate may be based on the following 
facts. In contrast o nuclear DNA, the genes are highly 
economically packed with no introns, punctuated by tRNA 
genes. Evolutionary, mammalian mtDNA down-sized to 
1/5 of yeast mtDNA losing introns. Thus, expression of 
the whole genome is essential for the maintenance of 
bioenergetic function, whereas only about 7% of the nu- 
clear genome is ever expressed at any particular differenti- 
ated stage. By a simple calculation, a 10-12-times faster 
mutation rate than that of nuclear DNA could be predicted. 
The mtDNA has neither a protective protein, such as 
historic, nor a repair system, and locates inside the inner 
mitochondrial membrane where reactive oxygen species 
are constantly generated from the normal electron-trans- 
port activity. In addition, cytochrome c efficiently trans- 
forms hydrogen peroxide into hydroxyl radical [28]. So, 
mtDNA is readily prone to oxygen free-radical damage. It 
seems to be evolutionarily inevitable that the center of 
energy production be the target of the programmed cell- 
death machinery, and the genes coding the center have to 
be not tough but delicate, manageable with the active cell 
death machinery. In this manner, mtDNA acquires the 
hydroxyl radical damage and mutations, and the mutated 
mtDNA tend to accumulate in a cell, especially in the post 
mitotic cells. 
Yeast's (mit-) mutations are usually associated with a 
significant rise in the rate of deletion, (p - )  mutation. In 
man, also, the major somatic mutation in mtDNA is the 
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Fig. 7. The large deletion of mtDNA in a mitochondrail myopathy patient. The crossover region of a deleted mtDNA from a patient with mitochondrial 
myopathy was directly sequenced. The deletion spanned 7039 bp starting from nucleotide position 8624 on the 3'-side of the directly repeated 
(ATCCCCA) within the ATPase 6 gene, and ending at 15662 on the 3'-side of the direct repeat within the cytochrome b gene. The sequence of deleted 
mtDNA resulting in frame shift forms an open reading frame that predicts a 12 kDa hybrid protein composed of 32 amino acid residues from the 
N-terminal side of the ATPase subunit 6 and 75 amino acid residues from C-terminal side of the cytochrome b apoprotein. Such a hybrid protein would 
give the cell abnormal mitotic stimuli. 
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(p ) ,  which exists in a cell usually heteroplasmic with 
the wild-type DNAs. Some deletions were maternally in- 
herited [7], and most of these were somatically acquired 
during the life of an individual, leading to development of
non-atherosclerotic dysfunction of cells. We have detected 
multiple deletions in mtDNAs of the patients with mtCM 
[15]. The 7.4 kbp deletion, one of the multiple deletions, 
occurs commonly among the patients with mtCM and even 
normal aged people. The deletion was quantitatively ana- 
lyzed by the kinetic PCR method [45]. The deletion was 
detected without exception among aged subjects, as shown 
in Fig. 6A [11]. In addition, the ratio of mtDNA with a 7.4 
kbp deletion to the total DNA increased exponentially with 
age up to 7% at age 97 [log(deleted mtDNA percentage) = 
-3.23 + 0.0407 × age, r = 0.87, P < 0.01]. Extrapolation 
of the curve to 100% gives an age of 129 years as the 
maximum life expectancy of humans regarding the my- 
ocardial bioenergetic function. 
However, the mechanism for the occurrence of a large 
deletion had been unknown; neither intramolecular homol- 
ogous recombination nor slipped mispairing during replica- 
tion is satisfactory, because there are no reports of any 
orthodox recombination mechanisms, and no chance to 
expose long stretches of single-stranded DNA at any stage 
of mtDNA replication [46]. Sequencing of the deleted 
mtDNA revealed that a pseudo-recombination occurs be- 
tween direct repeats in two genes, as shown in Fig. 7. 
Namely, double-strand separation leading to the generation 
of long stretches of single-stranded DNA is a prerequisite 
to the occurrence of a large deletion. One possible mecha- 
nism for the double-strand separation is the hydroxyl 
radical damage to mtDNA, such as conversion of guanine 
to 8-hydroxyguanine. Despite the inherent antioxidant 
pathway in mitochondria, such as superoxide dismutase 
and glutathione peroxidase, certain reactive oxygen species, 
especially the hydroxyl radical, form adducts with 
nucleic-acid bases of mtDNA. Thus, over a period of 
years, the hydroxyl radical adducts accumulate, leading to 
double-strand separation and synergetic increase in the 
deletion of mtDNA [11]. Both the conformation and the 
electron negativity of 8-hydroxyguanine were found to be 
quite different from those of normal guanine [47] inducing 
a local DNA structure alternation such as B-to-Z transition 
[17]. It could be considered that accumulation of 8-hy- 
droxyguanine in mtDNA triggers its double-strand separa- 
tion, and thus the amount of 8-hydroxyguanine and of the 
deletion in mtDNA should be correlative. We have demon- 
strated with in vivo studies that 8-hydroxyguanine mas- 
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Fig. 8. Scheme for mtDNA mutations. Production of reactive oxygen spices is enhanced by both endogenous factors such as inherited point mutations ( ee 
Fig. 3) and exogenous factors such as toxins, drugs or viral infections. Damage of macromolecules due to reactive oxygen species is regulated by the 
protooncogene products, Bcl-2/Bax, of which levels are differentially affected by p53 protein [29]. Hydroxyl-radical dduct of guanosine, 8-OH-dG+ 
resulted in random point mutations and the double-strand separation leading to a long stretch of single-stranded DNA, then deletion. Defected 
electron-transport chain encoded by the deleted mtDNA enhances the hydroxyl-radical formation resulting in more accumulation of 8-OH-dG and ions in 
mitochondrial matrix. High concentration of ions also facilitate the double-strand separation. Such a vicious cycle of the oxygen free radical damage and 
deletion in mtDNA seems to result in those changes being synergistic and exponential, as demonstrated in Fig. 6. 
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sively accumulated in mtDNA of azidothymidine-adminis- 
tered mice, an experimental model of mitochondrial my- 
opathy, associating with deletions. In addition, it was 
demonstrated with in vitro studies that hydroxyl radical 
attacks mtDNA, converting its guanine to 8-hydroxy- 
guanine, efficiently catalyzed by cytochrome c [28]. 
Using the same human specimen as for the quantifica- 
tion of the deletion in Fig. 6A, the ratio of 8-OH-dG to 
(dG+ 8-OH-dG) in mtDNA hydrolysate was determined 
using the microHPLC/MS system [11,48]. Even among 
the normal aged people, the hydroxyl radical damage 
increases exponentially with age [log(8-OH-dG %) = -3.82 
+ 0.0401 X ages, r = 0.84, P < 0.01], as shown in Fig. 
6B. Accumulation of 8-OH-dG in mtDNA up to 1.5% of 
dG (one per 150 bp of mtDNA = 15 turns of double helix) 
could trigger the double-strand separation that is the pre- 
requisite for a large deletion. The analyses established a
clear correlation between the amount of the deleted mtDNA 
and the 8-OH-dG content [(deleted mtDNA percentage) = 
0.0715 + 4.734 x (8-OH-dG %), r = 0.93, P < 0.01]. As 
schematically illustrated in Fig. 8, the hydroxyl radical 
damage in mtDNA induces a large deletion. Conversely, a
defective mitochondrial respiratory chain encoded by the 
deleted mtDNA would enhance oxygen free-radical lbrma- 
tion, resulting in increased accumulation of the hydroxyl 
radical damage. Abnormal ion accumulation i to the mito- 
chondrial matrix due to energy deficit of the cell would 
also facilitate the double-strand separation of mtDNA. 
Such a vicious cycle of the oxygen free-radical damage 
and deletion results in those changes being synergistic and 
exponential, with a significant correlation, r = 0.93 [11]. 
These deteriorative sequences finally lead to cellular en- 
ergy deficit and death. Thus, the development of non- 
atherosclerotic neuromuscular dysfunction seems to be an 
inevitable progressive change during human life. Content 
of 8-OH-dG in the mtDNA hydrolysates from young pa- 
tients is shown in Fig. 6B. Both patients with mitochon- 
drial diseases, one female, died of heart failure at age 17, 
and one male died at age 19 (MCM, P-I  in Fig. 2), have 
accumulated 8-OH-dG equivalent o the normal control 
subjects of age 78. These diseases tarting at an early age 
could be regarded as premature ageing. 
The conventional survey of deletion by the Southern 
blot analysis or by their PCR analysis within the limited 
regions has provoked curiosity [46] in that there is no 
obvious correlation between the severity of the clinical 
symptoms or biochemical abnormality and either the loca- 
tion of the deletion or the number of deleted genes. This 
complication would result from two major factors. (a) 
Quantitative linearity of the Southern blot analysis is un- 
equivocally poor, especially at low doses of deleted 
mtDNA, due to its washing procedure. (b) The survey of 
mtDNA deletions by PCR, among several laboratories 
including ours, has been usually carried out within limited 
regions of mtDNA, avoiding the regions of both replica- 
tion origins (Or) of the L-strand and H-strand of mtDNA, 
OrL and OrH. This would result from a biased preconcep- 
tion that both OrL and OrH are essential for mammalian 
mtDNA replication, despite some evidence that discontinu- 
ous synthesis occurs in mammalian mtDNA [49] and in sea 
urchin oocytes [50]. To solve the complication i  the assay 
of deletion, it is necessary to locate the deletion span and 
to quantify the ratio of the deleted mtDNA to the total 
mtDNA. In our laboratory, several methods were devised 
for a rapid and accurate detection of the somatic mutations 
in human mtDNA: (a) primer-shift PCR method for local- 
izing and confirming mtDNA deletions [51]; (b) kinetic 
PCR to quantify the amount of the deleted mtDNA [45]; 
(c) micro high-performance liquid chromatography/mass 
spectrometry (microHPLC/MS) for the quantification of 
the oxygen free-radical damage in mtDNA [48]; (d) total 
detection system for deletion using 180 kinds of primer 
pairs [19]. Especially the method (d) is noteworthy. The 
primer pairs cover all regions of mtDNA circle locate each 
deletion. Simultaneously, the built-in principle of the 
primer-shift method (a) confirms that each deletion is not 
the primer's miss-matched product, but real one. 
The method (d) revealed that there were 235 different 
types of deletion of various sizes and locations in the heart 
mtDNA of MCM, P-l, in Fig. 3, who had one (mit-) 
mutation in the ND3 gene and one (syn-) mutation in the 
tRNA A~p gene as his germ-line point mutations. As shown 
in Fig. 2, there were 48 types of deletions in which both 
OrL and OrH were preserved, 59 types of deletions result- 
ing in mtDNA fragments lacking OrL but not OrH, 31 
types resulting in mtDNA fragments lacking OrH but not 
OrL, and 97 types lacking both OrL and OrH. The deleted 
mtDNA fragment with either incomplete or complete losses 
of Or could be regarded as "mtDNA minicircle". Al- 
though the replication mechanism of Or- mtDNA minicir- 
cles remains unknown, a replication mechanism similar to 
that observed in stable DNA replication mutants of Esh- 
erichia coli  without ori C [52] is likely to operate. The 
precise locations of the numbered eletions (Nos. 1 to 6) in 
Fig. 2 were determined by direct mtDNA sequencing 
across the deletion breakpoints. The common deletion (No. 
1) and the 7436 bp deletions (No. 2) have been previously 
shown to occur in an age-related manner [8,53]. Combina- 
tion of the method (c) and the method using an ethidium 
bromide agarose plate [54] revealed that the deleted mtDNA 
in the patient's mtDNA specimen accounted for 84% of 
the total, indicating extensive deletions leading to the 
generation of mtDNA minicircles. In contrast, there were 
67 types of deletion accounting for 23% of the total 
mtDNA in the (syn-) negative control (ID 119, in Fig. 3), 
who died from an accident at age 28, had an almost same 
germ-line mutations with MCM, P-l, except one (syn)  in 
the tRNA A~v gene. The method (d) also revealed that there 
were five different ypes of deletion in the biopsied heart 
mtDNA of a patient aged 3 years with a ventricular septal 
defect; 49 types of deletion accounting for 19% of the total 
mtDNA in the heart mtDNA of a man who died as the 
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result of an accident at age 24; and 358 types of deletion 
accounting for 88% of the total mtDNA of a woman who 
died from gastric cancer at age 97 (unpublished ata). 
These results indicate that the generation of mtDNA mini- 
circle is cumulative and age-associated, accelerated by the 
germ-line mutations leading to the patient's premature 
ageing. The amount of the common deletion in MCM, 
P-l, was 0.2%, almost similar to that of ID 119. Thus, the 
deletion analysis using one primer pair detecting the com- 
mon deletion will draw a naive conclusion that there is no 
difference between their mtDNA deletions. However, the 
common deletion could be regarded as the tip of an 
iceberg, one of 235 types of deletion. The comprehensive 
analyses of the deletions with 180 primer pairs, summa- 
rized in Fig. 2, demonstrate clear correlation of the dele- 
tions with the severity of clinical symptoms: MCM P- l 's  
heart size did not increase, but heart failure developed over 
a 10-year period with proliferation of abnormal mito- 
chondria and atrophies of muscle fibers (Fig. 4). In the 
terminal stage of disease, his heart failure was the 4th 
degree according to the New York Heart Association 
Standard. 
3. Clinical phenotype 
3.1. Maternal inheritance 
As the mitochondria in the sperm are detached at the 
time of fertilization, mtDNA is transmitted to a descendant 
exclusively from an oocyte. So, the patients with mito- 
chondrial diseases ometimes have family members with 
similar symptoms maternally inherited. This is in contrast 
to the familial diseases that show a typical menderian 
pattern of inheritance. Mitochondrial diseases often appear 
to be sporadic. 
3.2. Segregation of mutated genomes 
The maternally inherited germ-line mutations result in 
the somatic segregation of individual mtDNA during eu- 
karyotic cell division. It is suggested that the segregation 
can result in organ-specific manifestation of mitochondrial 
cytopathy; e.g., that in brain, skeletal muscle and my- 
ocardium in the case of MELAS, that in skeletal muscle in 
the case of mitochondrial myopathy, and that in my- 
ocardium in the case of mtCM. Such segregation or focal 
induction of the protooncogenes by the oxygen stress will 
also produce energy mosaic within a tissue whereby some 
cells of the tissue will be reasonably more bioenergetically 
competent than other cells. In Fig. 9, a focal deficit of 
cytochrome oxidase activity is demonstrated in an unrav- 
elled biopsied muscle fiber from a mitochondrial myopa- 
thy patient who had a heteroplasmic deletion that deletes 
cytochrome oxidase subunit 3 gene. Activity of cy- 
tochrome oxidase directly reflects the rate of ATP produc- 
tion. Thus, the energy mosaic near the neuromuscular 
junction could explain the patient's abnormal electromyog- 
raphy. Similarly, the energy mosaic among brain cells 
could explain the focal low-density area in CT scanning 
image among patients with mitochondrial encephalomy- 
Fig. 9. Energy mosaic in a muscle fiber of a mitochondriai myopathy patient. Biopsied muscle fibers from a patient who has heteroplasmic deletion in his 
mtDNA including cytochrome oxidase subunit 3 were unraveled and subjected to cytochrome oxidase activity staining. Focal destaining ( . ) ,  deficiency of 
the activity, indicated by an arrow, near the neuromuscular junction (N) could explain the abnormal electronmyograph of the patient. 
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opathy. As the somatic oxygen free-radical damage and the 
deletion in mtDNA increase exponentially with age (Fig. 
6), the energy mosaic in the neuromuscular cells would be 
an important contributor to senile ataxia and dementia. 
3.3. Cumulatil,e accumulation ~f mutations 
The accumulation of bioenergetically defective cells 
with time is a key factor in the process of ageing and 
mitochondrial disease. Thus, a progressive fall in the effi- 
ciency of the oxidative phosphorylation process occurs in 
the neuromuscular cell. Normal individuals naturally adjust 
their physical activities to compensate for this loss and it 
does not necessarily lead to any clinical treatment. How- 
ever, when there is an excessive increase in cell's energy 
demand under stress, there may be sudden death or severe 
impairment of the neuromuscular cell with pathological 
consequences. Idiopathic PD is a very common degenera- 
tive brain disease causing movement disorder. By calcula- 
tion, it was reported that about 1 person in 40 will become 
symptomatic with PD during normal lifetime [55]. As the 
disorder has a slight familial connection ot often follow- 
ing any clear menderian pattern of inheritance, a polygenic 
mode of inheritance and exposure to environmental factors 
have been proposed as the etiological factor. As introduced 
here, underlying mechanism of PD is progressive accumu- 
lation of polygenic deletion due to oxygen free radical, a 
prominent environmental factor. A similar exponential in- 
crease in the oxygen free-radical damage and the extent of 
deletions was detected in the mtDNA from diaphragm 
muscle [10,56]. These mutations would account for a 
progressive reduction of vital capacity and pulmonary 
compliance with an increase of residual volume in the 
elderly lung. Together with clinical and histochemical data 
relevant o the genetic mutations, such as mild left ventric- 
ular hypertrophy associated with age [57] and focal de- 
crease of cytochrome oxidase activity with age [58], it 
could be concluded that every individual will suffer from 
the neuromuscular mitochondrial disease to some extent 
with ageing. 
Patients with mtCM often show left ventricular hyper- 
plasia and negative T-wave, which is a sign of ventricular 
ischemia, despite the absence of vascular disorder. Due to 
the bioenergy mosaic in the myocardium, the patients 
suffered from arrhythmias as illustrated in Fig. 3. Some 
cases of HCM died of premature ventricular contraction. 
Cardiac output of DCM patients tended to decrease as the 
disease progressed, and the patients died of cardiac failure 
(DCM, P-2). Some patients displayed a transition from 
HCM to DCM (e.g., HCM, P-5). HCM, P-5 died by 
cerebral infarction with atrial fibrillation. Another case 
(HCM, P-3) displaying the transition from HCM to DCM 
died of heart failure and renal failure at age 45 [59]. 
Examination of the mtDNA from his autopsied heart 
demonstrated several serious germ-line point mutations 
similar to those of MCM, P-1 and multiple deletions. 
4. Conclusion and perspective 
The comprehensive analyses of the entire mtDNA re- 
vealed "the redox mechanism of ageing" that cumulative 
increase in the oxygen free-radical damage and the poly- 
genic deletions in mtDNA are associated with normal 
human ageing, and the germ-line point mutations in the 
patients with degenerative diseases potentially accelerate 
these degenerative changes, leading to their premature 
ageing (Figs. 2, 3 and 6). The analyses disclosed the clear 
relation between the genotype and phenotype of the pa- 
tients (Fig. 3 and 5). Further repletion of the genotypes 
database will make the genetic diagnosis more precise. 
The close relationship (r  = 0.93) between oxygen free- 
radical damage and the deletion leading to progressive 
decline of bioenergetic activities of cells and organs im- 
plies an underlying control mechanism of cell death relat- 
ing with the ageing process. Recent advances in the mech- 
anism of programmed cell-death have revealed that the 
mitochondrion is the major target of the apoptosis regulat- 
ing protooncogen products manipulating oxygen free-radi- 
cal damage, Bcl-2/Bax [24,25], the levels of which are 
differentially affected by p53 protein [29]. The revelation 
that human mtDNA has delicate susceptibility to hydroxyl 
radical attack, breaking into hundreds of pieces of minicir- 
cle (Fig. 2) will give insight to the active cell-death 
machinery, as its major target would be mtDNA. The 
active cell-death essential for human morphogenesis and 
development is reported to be related to oxygen free-radi- 
cal damage of macromolecules blocked by Bcl-2 [25]. 
However, the block seems to be imperfect, as there is 
cumulative oxygen damage and deletions in mtDNA asso- 
ciated with age (Fig. 6). From this standpoint, normal 
ageing and development seem to be the two sides of a 
coin. The cell-death machinery seems to be easily imbal- 
anced by the point mutations of the patient's mtDNA, 
leading to premature ageing (Figs. 2 and 6). 
The more precise mechanism of the control in the 
oxygen free-radical damage in the cell has to be clarified. 
The mechanism of the on-off switch that transforms mi- 
totic cell into postmitotic awaits clarification. Such infor- 
mation will form the basis of future genetic therapy for 
ageing and degenerative diseases associated with mtDNA 
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